Lopressor® / Toprol-XL®
Metoprolol is a selective beta-1 adrenergic blocker used for hypertension, angina, heart failure, and acute MI.
| Dosage Form | Oral Tablet (Immediate/Extended-Release) / IV Injectable |
| Strength | 25 mg, 50 mg, 100 mg, 200 mg (oral); 1 mg/mL (IV) |
| Storage | Store at 25°C. Protect from moisture and light. |
| Category | Cardiovascular |
| Availability | Available for Transfer |
Hypertension; angina pectoris; heart failure (stable NYHA II-III); acute MI; rate control in atrial fibrillation.
Selective beta-1 adrenergic receptor antagonist that reduces heart rate, cardiac output, and myocardial oxygen demand. At higher doses may also block beta-2 receptors.
Each Burrard Pharmaceuticals technology transfer package for Metoprolol includes comprehensive documentation and support:
Complete formulation with manufacturing parameters, excipient specifications, and process controls.
Validated methods for assay, impurities, dissolution, and stability-indicating analysis.
Market-ready regulatory dossier templates — available through Burrard Intelligence subscription.
ICH-compliant stability studies (accelerated and long-term) with detailed protocols.
Scale-up procedures, batch records, equipment specifications, and in-process controls.
Direct advisory access to formulation scientists and regulatory specialists throughout transfer.
Our team can deliver the complete know-how package within 2–21 business days. Book a consultation to discuss your specific requirements.